Results 11 to 20 of about 446,414 (163)

Anesthetic implications in hyperthermic intraperitoneal chemotherapy

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2019
Patients with peritoneal carcinomatosis were considered incurable with dismal survival rates till hyperthermic intraperitoneal chemotherapy after optimal cytoreductive surgery evolved. Perioperative management for these procedures is complex and involves
Nishkarsh Gupta   +5 more
doaj   +4 more sources

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [PDF]

open access: yesDiagnostics, 2020
Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual ...
McKayla J. Riggs   +3 more
doaj   +4 more sources

Hyperthermic Intraperitoneal Chemotherapy: A Critical Review [PDF]

open access: yesCancers, 2021
Simple Summary Patients with cancer of the digestive system or ovarian cancer are at risk of developing peritoneal metastases (PM). In some patients with PM, surgery followed by intraperitoneal (IP) chemotherapy has emerged as a valid treatment option ...
Demuytere, Jesse   +5 more
core   +6 more sources

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial

open access: yesInternational Journal of Hyperthermia, 2023
Objective To compare the efficacy and safety of hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy in the treatment of malignant pleural or peritoneal effusion.Methods A randomized ...
Lili Liu   +14 more
doaj   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

open access: yesAnnals of Surgical Oncology, 2023
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment modality that aims to target the main site of tumor dissemination in ovarian cancer, the peritoneum, by combining the benefits of intraperitoneal chemotherapy with the synergistic effects ...
Huang, Gloria S   +27 more
core   +3 more sources

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: An update

open access: yesHormone Molecular Biology and Clinical Investigation, 2020
International audienceIn the treatment of advanced-stage epithelial ovarian cancer (EOC)-associated surgery and chemotherapy with intravenous platinum/taxane-based therapy most patients had early or late recurrence.
Revaux, A.   +6 more
core   +4 more sources

Hyperthermic intraperitoneal chemotherapy: Ideal and reality

open access: yesAsian Journal of Surgery
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong   +8 more
doaj   +3 more sources

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge

open access: yesIndian Journal of Anaesthesia, 2014
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy plays a considerable role as a treatment modality in surgical oncology in western countries.
Kavita Murughan   +2 more
core   +4 more sources

Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy [PDF]

open access: yes, 2021
Cisplatin is one of the most widely used chemotherapeutic agents in oncology, although its nephrotoxicity limits application and dosage. We present the results of a clinical study on prophylaxis of cisplatin-induced nephrotoxicity in patients with ...
Vasquez-Jimenez, Wenceslao   +36 more
core   +1 more source

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [PDF]

open access: yesNew England Journal of Medicine, 2018
(Abstracted from N Engl J Med 2018;378:230–240) The majority of patients with ovarian cancer (OC) receive an initial diagnosis of advanced disease that has spread from the ovaries to the peritoneal surface. The most effective treatment for patients with advanced disease is cytoreductive surgery followed by systemic chemotherapy.
Willemien J. van Driel   +16 more
openaire   +16 more sources

Home - About - Disclaimer - Privacy